amfAR Institute for HIV Cure Research: An Interview with Dr. Paul...

Hide & Seek Paul Volberding, MD, helps create synergy at the amfAR Institute for Cure Research by Jeannie Wraight The amfAR Institute for HIV Cure Research was...

HTVN 702: Vaccine Candidate

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

Talking “Cure”

Nobel Prize Laureate and world renowned HIV researcher Françoise Barré-Sinoussi recently made the statement that she does not believe an HIV cure is possible....

Countdown to a Cure

by Jeannie Wraight As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...

Orphaned Vaccines

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Targeting HIV Reservoirs

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...

PaxVax’s Vaccine Platform & Other Research Build Momentum

Gaining Momentum HIV vaccine candidates seek to make good on their early promise by Jeannie Wraight and David Miller Over the past several years, momentum for the...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

Eye on the Future

Towards an HIV Cure is an initiative of the International AIDS Society (IAS) formed to help direct and facilitate discussion, research and policy to...

Women & PrEP

LifeGuide It's a Man's World Research on women & PrEP needs to keep pace by Jeannie Wraight   Whereas HIV cure and HIV prevention are two very different...

LATEST POSTS

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...

5B, or Not to 5B

Jason Bennett: Advocate